Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
0.360 GeneticVariation disease BEFREE In the present study, we aimed to investigate the clinicopathological aspects of a large series of follicular thyroid carcinomas (FTCs) in paediatric patients and to analyse the point mutations in codons 12, 13 and 61 of NRAS, HRAS and KRAS genes and the rearrangements of PAX8-PPARG. 28621837 2017
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
0.360 Biomarker disease CTD_human Bromodomain and Extraterminal Protein Inhibitor JQ1 Suppresses Thyroid Tumor Growth in a Mouse Model. 27440272 2017
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
0.360 GeneticVariation disease BEFREE None of FTCs had KRAS or HRAS mutations. 27264674 2016
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
0.360 GeneticVariation disease BEFREE In follicular thyroid carcinoma, NRAS was the most frequently observed mutation (4/9 patients), followed by HRAS (two patients) and KRAS (one patient). 26971368 2016
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
0.360 GeneticVariation disease BEFREE K-RAS codon 12-13 (n = 6, 31.6 %), N-RAS codon 61 (n = 5, 26.3 %), H-RAS codon 61 (n = 4, 21.1 %), K-RAS codon 61 (n = 3, 15.8 %), and N-RAS codon 12-13 (n = 1, 5.3 %) were found in FTCs, and N-RAS codon 61 (n = 10, 45 %), K-RAS codon 12-13 (n = 5, 22.7 %), H-RAS codon 61 (n = 5, 22.7 %), K-RAS codon 61 (n = 1, 4.5 %), and N-RAS codon 12-13 (n = 1, 4.5 %) were observed in FTAs. 25999051 2015
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
0.360 GeneticVariation disease BEFREE A total of 37 thyroid aspirates, including benign hyperplastic nodules (HBN, N = 16) and follicular thyroid carcinomas (FTC, N = 21) were analyzed for the presence of NRAS(61) and KRAS(13) mutations. 24866065 2014
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
0.360 AlteredExpression disease BEFREE Finally, KRAS2 was found to be differentially expressed (P<0.05) when comparing the papillary thyroid carcinoma and follicular thyroid carcinoma groups. 17660800 2007